Back to Atlas
CTransientStandard research/education caution
CMP-0260
Approved
Acarbose
Metabolic / Geroprotective
Metabolic health and lifespan-extension research positioning
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Small molecule
- Primary mechanism
- Alpha-glucosidase inhibition blunts postprandial glucose excursions
- Primary market use
- Metabolic / glucose control
Pharmacology
- Molecular weight (Da)
- 645.6
- Oral bioavailability
- Very low systemic absorption (<2%)
- Half-life
- ~2 h for absorbed fraction
- Route tags
- Route-dependent / verify
- Evidence level
- Approved/Human
- Clinical status
- Approved
- Value-for-money score
- 6 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Good value as metabolic modulator but effects require ongoing use